IL28B alleles exert an additive dose effect when applied to HCV-HIV coinfected persons undergoing peginterferon and ribavirin therapy

B.K. Dayyeh; N. Gupta; K.E. Sherman; P.I.W. de Bakker; x Aids Clinical Trials Group A5178 Study Team; R.T. Chung

IL28B alleles exert an additive dose effect when applied to HCV-HIV coinfected persons undergoing peginterferon and ribavirin therapy

Translated title of the contribution: IL28B alleles exert an additive dose effect when applied to HCV-HIV coinfected persons undergoing peginterferon and ribavirin therapy

B.K. Dayyeh
, N. Gupta
, K.E. Sherman
, P.I.W. de Bakker
, x Aids Clinical Trials Group A5178 Study Team
, R.T. Chung

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	IL28B alleles exert an additive dose effect when applied to HCV-HIV coinfected persons undergoing peginterferon and ribavirin therapy
Original language	Undefined/Unknown
Pages (from-to)	e25753-e25753
Number of pages	1
Journal	PLoS ONE [E]
Volume	6
Issue number	10
Publication status	Published - 2011

Keywords

Econometric and Statistical Methods: General
Geneeskunde(GENK)
Medical sciences
Bescherming en bevordering van de menselijke gezondheid

Access to Document

http://www.ncbi.nlm.nih.gov/pubmed?term=22003405

Cite this

@article{9efeb1c4b2e74ec0bdce4fe98f02268b,

title = "IL28B alleles exert an additive dose effect when applied to HCV-HIV coinfected persons undergoing peginterferon and ribavirin therapy",

keywords = "Econometric and Statistical Methods: General, Geneeskunde(GENK), Medical sciences, Bescherming en bevordering van de menselijke gezondheid",

author = "B.K. Dayyeh and N. Gupta and K.E. Sherman and \{de Bakker\}, P.I.W. and \{Aids Clinical Trials Group A5178 Study Team\}, x and R.T. Chung",

year = "2011",

language = "Undefined/Unknown",

volume = "6",

pages = "e25753--e25753",

journal = "PLoS ONE [E]",

issn = "1932-6203",

publisher = "Public Library of Science",

number = "10",

}

TY - JOUR

T1 - IL28B alleles exert an additive dose effect when applied to HCV-HIV coinfected persons undergoing peginterferon and ribavirin therapy

AU - Dayyeh, B.K.

AU - Gupta, N.

AU - Sherman, K.E.

AU - de Bakker, P.I.W.

AU - Aids Clinical Trials Group A5178 Study Team, x

AU - Chung, R.T.

PY - 2011

Y1 - 2011

KW - Econometric and Statistical Methods: General

KW - Geneeskunde(GENK)

KW - Medical sciences

KW - Bescherming en bevordering van de menselijke gezondheid

M3 - Article

SN - 1932-6203

VL - 6

SP - e25753-e25753

JO - PLoS ONE [E]

JF - PLoS ONE [E]

IS - 10

ER -